Addiction

Psychiatry·MeSH: Behavior, Addictive

20 drugs in development·16 companies·2 clinical trials

Drug Pipeline by Phase

Approved(14)

Drug	Company
hydrocodone bi	ANI PHARMACEUTICALS INC (ANIP)
hydrocodone bi	AGENUS INC (AGEN)
hydrocodone bi	SUNSET ISLAND GROUP (SUN)
methadone	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
morphine	Impax Laboratories, LLC (IPXL)
morphine	SUNSET ISLAND GROUP (SUN)
naltrexone	SUNSET ISLAND GROUP (SUN)
oxycodone	SUNSET ISLAND GROUP (SUN)
oxycodone	Nascent Biotech Inc. (NBIO)
qdolo	Alterity Therapeutics Limited (ATHE)
tramadol	GH Research PLC (GHRS)
tramadol	Prestige Consumer Healthcare Inc. (PBH)
tramadol	Mylan II B.V. (MYL)
tramadol	SUNSET ISLAND GROUP (SUN)

Preclinical(6)

Drug	Company
curefilm central nervous system	AVENIR WELLNESS SOLUTIONS, INC. (CURR)
cvsi-007	CV Sciences, Inc. (CVSI)
jan123	ALT5 Sigma Corp (ALTS)
psilocybin	Kaya Holdings, Inc. (KAYS)
supera-cbd	Q/C TECHNOLOGIES, INC. (QCLS)
tetrahydrocannobivarin pro	INNOVATION1 BIOTECH INC. (GMVP)

BioSniper tracks 20 drugs in development for Addiction across 16 companies.

There are 2 clinical trials targeting Addiction tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.